Turtle Creek Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Turtle Creek Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.67M	Sell	13,235 -460	-3%	-$60.6K	0.09%	126
2026 Q1	$1.91M	Buy	13,695 +4,251	+45%	+$595K	0.14%	102
2025 Q4	$1.16M	Buy	9,444 +2,229	+31%	+$271K	0.09%	136
2025 Q3	$801K	Buy	7,215 +2,726	+61%	+$310K	0.07%	156
2025 Q2	$498K	Buy	+4,489	New	+$478K	0.06%	169
2024 Q4	–	Sell	-2,844	Closed	-$238K	–	106
2024 Q3	$238K	Buy	+2,844	New	+$217K	0.05%	159
2024 Q1	–	Sell	-2,427	Closed	-$197K	–	442
2023 Q4	$197K	Buy	+2,427	New	+$189K	0.06%	148

Other funds holding GILD

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Turtle Creek Wealth Advisors's GILD Position: Q2 2026 in Review

Turtle Creek Wealth Advisors reduced its Gilead Sciences (GILD) stake by 3.4% in Q2 2026, selling an estimated $60.6K and leaving 13,235 shares worth $1.67M. The position accounts for 0.09% of the portfolio, ranked #126.

Turtle Creek Wealth Advisors first reported a position in GILD in Q4 2023 and has held it in 7 quarters since. The position peaked at $1.91M in Q1 2026. 1,154 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Turtle Creek Wealth Advisors held 13,235 shares of Gilead Sciences worth $1.67M as of Q2 2026.
Turtle Creek Wealth Advisors sold 460 Gilead Sciences shares in Q2 2026, an estimated $60.6K.
Gilead Sciences made up 0.09% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #126 holding.
Turtle Creek Wealth Advisors first reported a position in Gilead Sciences in Q4 2023 and has held it in 7 quarters since.
Turtle Creek Wealth Advisors's Gilead Sciences position peaked at $1.91M in Q1 2026.
1,154 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.